Fallopian Tube Cancers: Clinical Trials

2 trials for Fallopian Tube Cancers, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 recruiting. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Not yet recruiting 1, Recruiting 1
Phase 21Recruiting 1

Follow Fallopian Tube Cancers: new trials by email Literature Review of Fallopian Tube Cancers trials Research Report on Fallopian Tube Cancers

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in Homologous Recombination Deficient Primary Ovarian Cancer, Fallopian-Tube Cancer, or Primary Peritoneal Cancer
PARP inhibitor + Bevacizumab, PARP inhibitor - Ovarian Cancer, Fallopian Tube Cancers
Phase 2 / Phase 3RecruitingN.N. Alexandrov National Cancer Centre1202025-07-012026-03-16
JSKN003 in Platinum-Resistant, Relapsed Epithelial Ovarian Cancer
JSKN003, Doxorubicin, Paclitaxel - Ovarian Cancer, Primary Peritoneal
Phase 3Not yet recruitingJiangsu Alphamab Biopharmaceuticals Co., Ltd4302025-01-152024-12-31

Narrower conditions

Fallopian Tube Neoplasms (2)  ·  Ovarian Neoplasms (2)

Broader conditions

Adnexal Diseases (2)  ·  Endocrine Gland Neoplasms (2)  ·  Endocrine System Diseases (2)  ·  Fallopian Tube Diseases (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Female (2)  ·  Genital Neoplasms, Female (2)  ·  Gonadal Disorders (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Ovarian Diseases (2)  ·  Urogenital Diseases (2)  ·  Urogenital Neoplasms (2)

Interventions

Bevacizumab (1)  ·  Doxorubicin (1)  ·  Paclitaxel (1)  ·  Poly(ADP-ribose) Polymerase Inhibitors (1)  ·  Topotecan (1)

Sponsors

Jiangsu Alphamab Biopharmaceuticals Co., Ltd (1)  ·  N.N. Alexandrov National Cancer Centre (1)

Countries

Belarus (1)